You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HIV-uninfected patients

Showing 1 - 25 of 8,248
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial (763SIP8/MPLA-5 vaccine)

Not yet recruiting
  • Healthy
  • 763SIP8/MPLA-5 vaccine
  • (no location specified)
Mar 15, 2023

dTap Vaccine Trial in Johannesburg (Adacel (Tdap))

Not yet recruiting
  • dTap Vaccine
  • Adacel (Tdap)
  • Johannesburg, GP, South Africa
    Chris Hani Baragwanath Academic Hospital
Mar 2, 2022

HIV Trial in United States (PGT121.414.LS, VRC07-523LS)

Completed
  • HIV Infections
  • PGT121.414.LS
  • VRC07-523LS
  • Los Angeles, California
  • +4 more
Jan 31, 2023

Blood and Reproductive Fluids in HIV-Infected and

Recruiting
  • HIV
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    HIV Trial in United States (MPER-656 Liposome Vaccine, Placebo for MPER-656 Liposome Vaccine)

    Completed
    Has Results
    • HIV Infections
    • MPER-656 Liposome Vaccine
    • Placebo for MPER-656 Liposome Vaccine
    • Birmingham, Alabama
    • +5 more
    Jun 15, 2022

    HIV Trial in Bangkok (IHV01, A244, ALFQ)

    Recruiting
    • HIV
    • IHV01
    • +3 more
    • Bangkok, Thailand
    • +1 more
    Feb 15, 2022

    HIV, Systemic Lupus Erythematosus Trial in Durham (AIDSVAX® B/E)

    Completed
    Has Results
    • HIV Infections
    • Systemic Lupus Erythematosus
    • AIDSVAX® B/E
    • Durham, North Carolina
      Duke Human Vaccine Institute CRS
    Jan 31, 2022

    HPV Infection, Hiv, HPV Vaccine Trial in Swaziland (Gardasil ® 9)

    Recruiting
    • HPV Infection
    • +2 more
    • Gardasil ® 9
    • Bulembu, Swaziland
    • +7 more
    May 16, 2022

    Tuberculosis, HIV Trial in Haiti, India, South Africa (Bedaquiline)

    Recruiting
    • Tuberculosis
    • HIV Infections
    • Port-au-Prince, Haiti
    • +4 more
    Jun 15, 2022

    HIV Trial in Boston (CH505 TF chTrimer, 3M-05-AF, Aluminum hydroxide suspension)

    Active, not recruiting
    • HIV Infections
    • CH505 TF chTrimer
    • +2 more
    • Boston, Massachusetts
      Brigham and Women's CRS
    Jan 31, 2022

    HIV Trial in United States (BG505 MD39.3 mRNA, BG505 MD39.3 gp151 mRNA, BG505 MD39.3 gp151 CD4KO mRNA)

    Suspended
    • HIV Infections
    • BG505 MD39.3 mRNA
    • +2 more
    • Birmingham, Alabama
    • +9 more
    Feb 1, 2023

    Healthy Trial in Rwanda, United States (Ad26.Mos.HIV, Ad26.Mos4.HIV, Clade C gp140)

    Completed
    • Healthy
    • Ad26.Mos.HIV
    • +3 more
    • Birmingham, Alabama
    • +9 more
    Jul 5, 2022

    Tuberculosis, Pulmonary Trial in Observatory (Atorvastatin 40mg, Placebo oral tablet)

    Recruiting
    • Tuberculosis, Pulmonary
    • Atorvastatin 40mg
    • Placebo oral tablet
    • Observatory, WC, South Africa
      General Medicine & Global Health, Cape Heart Institute, Faculty
    Oct 13, 2022

    HIV/AIDS Trial in Orlando, Boston, Houston (PGT121 + VRC07-523LS, PGT121 + VRC07-523LS + PGDM1400)

    Completed
    • HIV/AIDS
    • PGT121 + VRC07-523LS
    • PGT121 + VRC07-523LS + PGDM1400
    • Orlando, Florida
    • +2 more
    May 6, 2022

    COVID-19 Trial in South Africa (Ad26.COV2.S (VAC31518, JNJ-78436735) Vaccine, SARS-CoV-2 rS (CovovaxTM), BNT162b2 (Pfizer))

    Recruiting
    • COVID-19
    • Ad26.COV2.S (VAC31518, JNJ-78436735) Vaccine, SARS-CoV-2 rS (CovovaxTM), BNT162b2 (Pfizer)
    • Pretoria, Gauteng, South Africa
    • +4 more
    Aug 23, 2022

    HIV Trial in Boston, Seattle (VRC07-523LS)

    Completed
    Has Results
    • HIV Infections
    • VRC07-523LS
    • Boston, Massachusetts
    • +1 more
    Mar 4, 2022

    HIV Trial (DNA-HIV-PT123, NYVAC-HIV-PT1, NYVAC-HIV-PT4)

    Withdrawn
    • HIV Infections
    • DNA-HIV-PT123
    • +4 more
    • (no location specified)
    Oct 13, 2021

    HIV-1-infection Trial in Amsterdam (ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes)

    Active, not recruiting
    • HIV-1-infection
    • ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes
    • Amsterdam, Noord-Holland, Netherlands
      Amsterdam University Medical Centers, location AMC
    Jan 31, 2023

    HIV Trial in Boston (env (A,B,C,A/E)/gag (C) DNA Vaccine, gp120 (A,B,C,A/E) Protein Vaccine, GLA-SE adjuvant)

    Active, not recruiting
    • HIV Infections
    • env (A,B,C,A/E)/gag (C) DNA Vaccine
    • +3 more
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jun 8, 2022

    HIV Trial in Kampala (VRC-HIVDNA009-00-VP, Placebo vaccine)

    Completed
    • HIV Infections
    • VRC-HIVDNA009-00-VP
    • Placebo vaccine
    • Kampala, Uganda
      Makerere University Walter Reed Project (MUWRP)
    Oct 28, 2021

    HIV Trial (DNA-HIV-PT123 vaccine, NYVAC-HIV-PT1 vaccine, NYVAC-HIV-PT4 vaccine)

    Withdrawn
    • HIV Infections
    • DNA-HIV-PT123 vaccine
    • +4 more
    • (no location specified)
    Oct 13, 2021

    HIV Trial in Switzerland, United States (VRC07-523LS, Placebo)

    Completed
    Has Results
    • HIV Infections
    • VRC07-523LS
    • Placebo
    • Birmingham, Alabama
    • +6 more
    Feb 21, 2022

    HIV Trial (1% tenofovir gel, Placebo gel)

    Withdrawn
    • HIV Infections
    • 1% tenofovir gel
    • Placebo gel
    • (no location specified)
    Oct 28, 2021

    HIV Trial in Cleveland, Philadelphia (HIV-1 nef/tat/vif, env pDNA vaccine, rVSV HIV envC vaccine, Placebo)

    Completed
    • HIV Infections
    • HIV-1 nef/tat/vif, env pDNA vaccine
    • +2 more
    • Cleveland, Ohio
    • +1 more
    Oct 13, 2021

    HIV, Insulin Sensitivity, Diabetes Trial in Gaborone (Zidovudine, Nevirapine)

    Completed
    • HIV
    • +2 more
    • Gaborone, Botswana
      Botswana-Harvard AIDS Institute Partnership
    Jul 18, 2022